Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$86.1M
57M shares
52-week range
$1.19 – $3.87
1% from low
Sector
CIGARETTES
Exchange
NASDAQ
CS
Borrow rate
2.83%
Moderate
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue | $63.4M | $88.1M | $115.6M | $151.9M | $127.5M |
| Cost of revenue | $53.0M | $74.8M | $94.8M | $122.1M | $104.8M |
| Gross profit | $10.4M | $13.3M | $20.8M | $29.8M | $22.6M |
| Gross margin | 16.4% | 15.1% | 18.0% | 19.6% | 17.8% |
| R&D | $0 | $0 | $0 | $0 | $0 |
| Operating income | $3.6M | −$988.7K | −$4.5M | −$13.9M | −$37.8M |
| EBITDA | $3.9M | −$656.5K | −$3.7M | −$11.8M | −$35.8M |
| Net income | $2.9M | −$1.9M | −$6.0M | −$14.8M | −$39.2M |
| Net margin | 4.6% | -2.1% | -5.2% | -9.7% | -30.8% |
| EPS (diluted) | 0.06 | -0.04 | -0.11 | -0.27 | -0.69 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $95M | $-0.36 | $-0.36–$-0.36 | 1 |
| 2027 | $113M | $-0.03 | $-0.03–$-0.03 | 1 |
| 2028 | $179M | $0.03 | $0.03–$0.03 | 1 |
Forward consensus · source: Financial Modeling Prep
Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping products in the United States, Europe, Canada, and South Africa. Geographically, the company generates the majority of its revenue from Europe.
www.ispiretechnology.comNo one on the platform currently holds ISPR.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 12,400 | $22.8K |
No one on the platform has traded ISPR yet.
| $50M |
| — |
| HFFGHF Foods Group Inc. | $1.65 | -8.33% | $88M | — |
| LFVNLifeVantage Corporation | $6.62 | -0.45% | $84M | — |
Source: Financial Modeling Prep · peers by sector/industry
Trading at 0.5× sales vs its 2.7× historical median P/S.
Fair value ≈ $6.88 · price $1.21 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$ISPR presented its annual meeting results, with shareholders electing five directors and ratifying Marcum Asia as audit firm.
View on StockTwits ↗$CHUC $ISPR https://nicotineinsider.com/2026/06/16/ninth-circuit-presses-fda-on-vape-flavor-review-standard/
View on StockTwits ↗$CHUC $ISPR When investors cite JUUL's $38B valuation, they're often using it as a proof that the market can place enormous values on nicotine-platform companies. The more difficult question is whether today's regulatory shifts make a future nicotine company more valuable because the pathway is clearer, or less valuable because the market is now more constrained and regulated. My thesis is that the clarity itself creates value—especially for $CHUC, who already invested heavily in PMTAs and compliance before the market recognized their importance.
View on StockTwits ↗$CHUC $ISPR The famous ~$38 billion valuation came when Altria Group invested in JUUL in 2018. For CHUC, the bull thesis is different. It's not: "We dominate the vape market today." It's closer to: "We own a large portfolio of regulatory assets that may become substantially more valuable under an evolving FDA framework." Those are not valued the same way- but a $38B valuation would imply that the buyer believes CHUC has become one of the most strategically important nicotine assets in the world.
View on StockTwits ↗$ISPR this chart has become surprisingly hard to argue with.
View on StockTwits ↗Top Gainers PT2 $GIPR $MTVA $SVRN $CODX $ISPR
View on StockTwits ↗$ISPR Great piece that accurately captures ISPR's current position. So if you want to refresh your understanding of ISPR or learn about ISPR for the first time, this is essential reading. https://everyticker.com/quote/ISPR/analysis/ispire-technology-s-triple-threat-malaysia-manufacturing-age-gating-tech-and-financial-turnaround-nasdaq-ispr
View on StockTwits ↗$CHUC $ISPR $MO https://finance.yahoo.com/markets/stocks/articles/americas-second-largest-c-store-130000758.html
View on StockTwits ↗$ISPR Share Price: $1.69 Contract Selected: Aug 21, 2026 $2.5 Calls Buy Zone: $0.13 – $0.16 Target Zone: $0.24 – $0.29 Potential Upside: 76% ROI Time to Expiration: 98 Days | Updates via https://fxcapta.com/stockinfo/
View on StockTwits ↗$CHUC $ISPR “Glas Inc. is based in Los Angeles. The products the FDA just authorized are American-made. RFK Jr.’s critique of the previous regulatory environment was explicitly framed around the harm done to U.S. manufacturers. The crackdown on Chinese illegal vapes creates market space for domestic products. The authorization of an American company’s flavored products fills some of that space with something legal and regulated.”
View on StockTwits ↗$CHUC $ISPR https://spinfuel.com/why-rfk-jr-and-the-fda-american-vapers/
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.